Skip to main content
Metagenomi, Inc. logo

Metagenomi, Inc. — Investor Relations & Filings

Ticker · MGX ISIN · US59102M1045 US Professional, scientific and technical activities
Filings indexed 124 across all filing types
Latest filing 2025-08-12 Interim / Quarterly Rep…
Country US United States of America
Listing US MGX

About Metagenomi, Inc.

https://metagenomi.co/

Metagenomi, Inc. is a genetic medicines company that develops curative therapeutics using its proprietary genome editing toolbox. The company's approach is founded on metagenomics, the study of genetic material recovered from natural environments, to discover and engineer novel gene editing systems. Its wholly-owned toolbox is designed to be capable of correcting various types of genetic mutations through site-specific deletion, integration, and correction. Metagenomi leverages high-throughput screening and AI-based cloud computing to expand its portfolio of editing technologies, focusing on disease indications with well-understood biology and clear clinical development pathways.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2025
2025-08-12 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 12, 2025, by Metagenomi, Inc. It announces the company's financial results for the quarter ended June 30, 2025, and includes a press release (Exhibit 99.1) and a corporate presentation (Exhibit 99.2). The text explicitly states that the press release is being furnished and is not "filed" for purposes of Section 18 of the Exchange Act, indicating this is an announcement rather than the full financial report itself. The document length is 4238 characters, which is relatively short and consistent with a current report announcing earnings results rather than containing detailed financial statements or analysis. Therefore, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2025-08-12 English
Regulatory Filings 2025
Regulatory Filings
2025-07-10 English
4
Director's Dealing
2025-06-12 English
4
Director's Dealing
2025-06-12 English
4
Director's Dealing
2025-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.